Clinical trial Recruiting at 3 sites Observational Ages 18 and up

Understanding how patients tolerate fluid removal during kidney support in the ICU

Official title: Volume Removal Intolerance During Net Ultrafiltration in Acute Kidney Injury Patients

Run by Hospital Las Higueras · NCT07643597 · Data updated 2026-11-12

This observational study tests how well critically ill adults with acute kidney injury tolerate net fluid removal during continuous renal replacement therapy.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment128 (estimated)
SponsorHospital Las Higueras
Academic / other
Locations10 sites (Salvador and 9 other locations)
StatusRecruiting
StartedJuly 6, 2026
Main results expectedDecember 1, 2027
Study endsDecember 1, 2027
Registry record updatedJuly 8, 2026
Trial IDNCT07643597 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults in the ICU with AKI requiring CRRT with net ultrafiltration and who are clinically stable enough to start UFNET per treating team.

Probably not a fit

Patients who do not experience intolerance or who have contraindications to UFNET may not see a direct benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective observational study follows adults with AKI in the ICU who are receiving CRRT with net ultrafiltration. It aims to identify factors—clinical, hemodynamic, ultrasound, perfusion, and biochemical—that predict ultrafiltration intolerance before overt hypotension occurs. No changes to treatment decisions are made by the study team; care remains with the treating clinicians. The study uses a multiparametric assessment to better understand who is at risk of intolerance during fluid removal.

Why it matters

Potential benefit: If successful, the findings could help tailor fluid removal strategies to reduce intolerance and related complications.

How similar studies have gone: Prior work suggests ultrafiltration tolerance is variable; this study builds on observational data but may be among the first to use a multiparametric approach for early risk identification.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥18 years
* Admission to an Intensive Care Unit
* Acute kidney injury according to KDIGO criteria
* Prescription of continuous renal replacement therapy (CRRT) with net ultrafiltration
* Clinical stability considered sufficient to initiate net ultrafiltration according to the treating clinical team

Exclusion Criteria:

* Chronic kidney replacement therapy prior to ICU admission
* Pregnancy
* Limitation of therapeutic effort or goals-of-care decisions at admission or during the observation period
* Inability to perform hemodynamic or perfusion assessment
* Extracorporeal membrane oxygenation (ECMO)
* Refusal to participate in the study

Where it's running

  • Hospital Las Higueras de Talcahuano
    Talcahuano, Chile
    Recruiting
  • Hospital Universitario San José de Popayán
    Popayán, Colombia
    Recruiting
  • Hospital General de Mexico
    Mexico City, Mexico
    Recruiting
  • Hospital Cárdio Pulmonar
    Salvador, Brazil
    Not yet recruiting
  • Hospital Clínico Regional de Concepción
    Concepción, Chile
    Not yet recruiting
  • Complejo Asistencial Dr. Victor Ríos Ruiz
    Los Ángeles, Chile
    Not yet recruiting
Show 4 more locations
  • Hospital Clínico Dra. Eloísa Díaz Insunza de La Florida
    Santiago, Chile
    Not yet recruiting
  • Hospital General Enrique Garces
    Quito, Ecuador
    Not yet recruiting
  • Ospedale San Bortolo
    Vicenza, Italy
    Not yet recruiting
  • Hospital Nacional Cayetano Heredia
    Lima, Peru
    Not yet recruiting

Study contacts

  • Principal investigator: Gonzalo Ramírez-Guerrero, MD — Hospital Las Higueras de Talcahuano
  • Study coordinator: Gonzalo Ramírez-Guerrero, MD
  • Email: ramirezguerrero.g@gmail.com
  • Phone: +56981746173

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.